Is Zika congenital syndrome, which affected thousands of babies born in Brazil during epidemics, associated with an increased host genetic susceptibility? And could Zika be a strong oncolytic agent against aggressive brain tumors? Find out in this opinion piece.
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
For the first time, Brazilian researchers have demonstrated the efficacy of the Zika virus in treating advanced-stage human CNS tumors in vivo.
With Zika research primarily focusing on in utero infections, new work has used a monkey model to study infants infected in their first year of life, uncovering adverse neurological consequences.
Roche has this week announced the launch of a new fully-automated IgG Zika assay, Elecsys®, which it hopes will help address the urgent need for accurate Zika diagnosis.
A recent study has presented an accurate estimation of pregnancy outcomes associated with Zika infection in French territories in the Americas.
A new test could extend the window for accurately detecting Zika virus, presenting a fast, cheap alternative.
In this editorial, the authors assess the insights that could be provided by PET imaging in evaluating and understanding the progression of neurological sequale in Zika virus.
The gene-editing technique CRISPR could be used to detect infections, potentially revolutionizing the detection of viruses such as HPV and Zika, according to two papers recently published in Science.
Listen to our podcast rounding up the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.
